SCHEMBL7606752

SCHEMBL7606752

CCN(O)C(=O)c1ccncc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.49
KMT2A Q03164 3/20 0.49
MLYCD O95822 2/20 0.47
NAPRT Q6XQN6 1/20 0.45
CYP1A2 P05177 2/20 0.44
CYP3A4 P08684 2/20 0.44
CYP2D6 P10635 2/20 0.44
CYP2C19 P33261 2/20 0.44
MPO P05164 1/20 0.44
ADORA3 P0DMS8 1/20 0.44
CYP2A6 P11509 1/20 0.44
NPSR1 Q6W5P4 1/20 0.43
USP2 O75604 1/20 0.43
LMNA P02545 1/20 0.42
ALDH1A1 P00352 2/20 0.42
HTT P42858 1/20 0.42
NAMPT P43490 1/20 0.41
PLOD2 O00469 1/20 0.41
PLOD3 O60568 1/20 0.41
CYP2C9 P11712 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9123942 0.85 HPGD (0.48) KMT2AMLYCDLMNAALDH1A1HPGD
SCHEMBL5710878 0.82 HPGD (0.56) KDM4EKMT2AMLYCDNAPRTUSP2
SCHEMBL11873778 0.80 NAPRT (0.45) KDM4EKMT2AMLYCDNAPRTCYP1A2
SCHEMBL8422261 0.80 NAMPT (0.58) KDM4EKMT2AMLYCDNAPRTCYP1A2
SCHEMBL16794763 0.79 ALDH1A1 (0.58) LMNAALDH1A1HPGDHDAC1GAA
SCHEMBL27854800 0.78 KDM4E (0.47) KDM4EKMT2AMLYCDNAPRTCYP1A2
SCHEMBL12853918 0.78 HTT (0.63) KDM4EKMT2ANPSR1USP2LMNA
SCHEMBL16875731 0.78 ALDH1A1 (0.52) ALDH1A1HPGDCA1CA9TP53
SCHEMBL10725189 0.77 KDM4E (0.58) KDM4EKMT2AMLYCDNAPRTCYP1A2
SCHEMBL27662505 0.76 NAPRT (0.54) KDM4EKMT2AMLYCDNAPRTCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-2002514185-A 2002-05-14 JP claimed
EP-0949922-A1 PHARMACEUTICAL COMPOSITIONS AND METHODS OF TREATING COMPULSIVE DISORDERS USING NAALADASE INHIBITORS GUILFORD PHARMACEUTICALS INC. (US) 1999-10-20 EP claimed
WO-1998013044-A1 PHARMACEUTICAL COMPOSITIONS AND METHODS OF TREATING COMPULSIVE DISORDERS USING NAALADASE INHIBITORS GUILFORD PHARMACEUTICALS INC. (US) 1998-04-02 WO claimed